Common Contracts
4 similar Exchange Agreement contracts by Teligent, Inc.
EXCHANGE AGREEMENTExchange Agreement • September 23rd, 2020 • Teligent, Inc. • Pharmaceutical preparations
This Exchange Agreement (this “Agreement”) is dated September 22, 2020 (the “Effective Date”), by and among each of the undersigned entities (the “Undersigned Entities” and each an “Undersigned Entity”), for itself and on behalf of the beneficial owners listed on Exhibit A hereto (“Accounts”) for whom such Undersigned Entity holds contractual and investment authority (each Account, as well as such Undersigned Entity exchanging Old Notes (as defined below) hereunder, a “Holder”), and Teligent, Inc., a Delaware corporation (the “Company”).
EXCHANGE AGREEMENTExchange Agreement • September 23rd, 2020 • Teligent, Inc. • Pharmaceutical preparations
This Exchange Agreement (this “Agreement”) is dated September 22, 2020 (the “Effective Date”), by and among each of the undersigned entities (the “Undersigned Entities” and each an “Undersigned Entity”), for itself and on behalf of the beneficial owners listed on Exhibit A hereto (“Accounts”), if any, for whom such Undersigned Entity holds contractual and investment authority (each Account, as well as such Undersigned Entity exchanging Old Notes (as defined below) hereunder, a “Holder”), and Teligent, Inc., a Delaware corporation (the “Company”).
EXCHANGE AGREEMENTExchange Agreement • July 20th, 2020 • Teligent, Inc. • Pharmaceutical preparations
This Exchange Agreement (this “Agreement”) is dated July 20, 2020 (the “Effective Date”), by and among each of the undersigned individuals or entities (the “Undersigned Entities” and each an “Undersigned Entity”), for itself and on behalf of the beneficial owners listed on Exhibit A hereto (“Accounts”) for whom such Undersigned Entity holds contractual and investment authority (each Account, as well as such Undersigned Entity if it is exchanging Old Notes (as defined below) hereunder, a “Holder”), Teligent, Inc., a Delaware corporation, (the “Company”), and the entities listed on the signature pages hereof as the initial “Subsidiary Guarantors” (the “Subsidiary Guarantors”).
EXCHANGE AGREEMENTExchange Agreement • July 20th, 2020 • Teligent, Inc. • Pharmaceutical preparations
This Exchange Agreement (this “Agreement”) is dated July 20, 2020 (the “Effective Date”), by and among each of the undersigned individuals or entities (the “Undersigned Entities” and each an “Undersigned Entity”), for itself and on behalf of the beneficial owners listed on Exhibit A hereto (“Accounts”) for whom such Undersigned Entity holds contractual and investment authority (each Account, as well as such Undersigned Entity if it is exchanging Old Notes (as defined below) hereunder, a “Holder”), Teligent, Inc., a Delaware corporation, (the “Company”), and the entities listed on the signature pages hereof as the initial “Subsidiary Guarantors” (the “Subsidiary Guarantors”).
